image
Pieris Pharmaceuticals, Inc. PIRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 15.8679
-0.202 %
$ 21 M
Market Cap
-0.83
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 65.28% 21.47% 31.55%
Annual Report FY 10-K 2022-12-31 -17.56% 27.93% 16.12%
Annual Report FY 10-K 2021-12-31 7.14% -16.48% -52.80%
Annual Report FY 10-K 2020-12-31 -36.64% -56.72% -24.91%
Annual Report FY 10-K 2019-12-31 59.03% 11.21% 11.92%
Annual Report FY 10-K 2018-12-31 15.14% -51.61% -111.26%
Annual Report FY 10-K 2017-12-31 333.48% 22.60% 35.88%
Annual Report FY 10-K 2016-12-31 98.87% -62.17% -66.35%
Annual Report FY 10-K 2015-12-31 -45.35% -42.73% -90.06%
Annual Report FY 10-K 2014-12-31 -45.70% -14880.00% -1299.73%
Annual Report FY 10-K 2013-12-31 -13.21% 102.85% 125.40%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 73.15% 73.45%
Quarterly Report Q2 8-K 2024-06-30 0.00% -90.29% -202.47%
Quarterly Report Q1 8-K 2024-03-31 -97.26% 60.27% 65.81%
Quarterly Report Q4 8-K 2023-12-31 -77.78% 43.24% 52.41%
Quarterly Report Q3 8-K 2023-09-30 263.50% -26.03% 2.97%
Quarterly Report Q2 8-K 2023-06-30 442.32% 138.46% 116.73%
Quarterly Report Q1 8-K 2023-03-31 -82.38% -348.52% -108.01%
Quarterly Report Q4 8-K 2022-12-31 -30.76% 11.83% -4.73%
Quarterly Report Q3 8-K 2022-09-30 32.36% 48.41% 36.00%
Quarterly Report Q2 8-K 2022-06-30 12.57% 33.29% 26.44%
Quarterly Report Q1 8-K 2022-03-31 -29.71% 34.20% -47.40%
Quarterly Report Q4 8-K 2021-12-31 349.81% 36.39% 11.38%
Quarterly Report Q3 8-K 2021-09-30 38.04% -15.77% -46.26%
Quarterly Report Q2 8-K 2021-06-30 -70.79% -213.09% -260.06%
Quarterly Report Q1 8-K 2021-03-31 17.89% -15.99% -31.20%
Quarterly Report Q4 8-K 2020-12-31 -89.13% -1767.70% -833.16%
Quarterly Report Q3 8-K 2020-09-30 -80.58% -451.04% -346.09%
Quarterly Report Q2 8-K 2020-06-30 110.92% 57.90% 61.94%
Quarterly Report Q1 8-K 2020-03-31 55.19% 65.24% 63.91%
Quarterly Report Q4 8-K 2019-12-31 251.44% 93.40% 89.48%
Quarterly Report Q3 8-K 2019-09-30 81.33% 57.87% 62.66%
Quarterly Report Q2 8-K 2019-06-30 -54.39% -5692.12% -445.25%
Quarterly Report Q1 8-K 2019-03-31 105.80% -18.75% -31.31%
Quarterly Report Q4 8-K 2018-12-31 -72.93% -155.96% -194.96%
Quarterly Report Q3 8-K 2018-09-30 112.49% 12.83% -50.53%
Quarterly Report Q2 8-K 2018-06-30 530.97% 97.99% 71.58%
Quarterly Report Q1 8-K 2018-03-31 209.09% -9.01% -1.63%
Quarterly Report Q4 8-K 2017-12-31 565.95% 214.21% 201.29%
Quarterly Report Q3 8-K 2017-09-30 400.28% -13.92% 16.08%
Quarterly Report Q2 8-K 2017-06-30 72.68% -71.42% -36.17%
Quarterly Report Q1 8-K 2017-03-31 7.72% -92.11% -82.75%
Quarterly Report Q4 8-K 2016-12-31 27.40% -125.99% -149.67%
Quarterly Report Q3 8-K 2016-09-30 89.33% -57.98% -59.23%
Quarterly Report Q2 8-K 2016-06-30 439854.10% -66.66% -63.97%
Quarterly Report Q1 8-K 2016-03-31 328923.75% -12.32% -18.35%
Quarterly Report Q4 8-K 2015-12-31 -34.77% 57.48% -69.30%
Quarterly Report Q3 8-K 2015-09-30 2114.32% -28081.15% -27776.72%
Quarterly Report Q2 8-K 2015-06-30 -0.03% -56762.10% -56833.47%
Quarterly Report Q1 8-K 2015-03-31 -99.97% -239843.91% -239623.64%
Quarterly Report Q4 8-K 2014-12-31 -4.25% -310397.13% -68838.72%
Quarterly Report Q3 8-K 2014-09-30 0.00% -141.55% -141.55%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%